|
UGT2B15 with BSA assay
|
BAO_0010182 |
|
|
UGT2B7 without BSA assay
|
BAO_0010185 |
|
|
UGT2B7 with BSA assay
|
BAO_0010184 |
|
|
sensitiser
|
CHEBI_139492 |
|
|
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor
|
CHEBI_64033 |
|
|
skeletal muscle neoplasm
|
DOID_4044 |
|
|
hair follicle neoplasm
|
DOID_5375 |
|
|
pilomatrixoma
|
DOID_5374 |
|
|
skin pilomatrix carcinoma
|
DOID_5376 |
|
|
hemoglobin E disease
|
DOID_5379 |
|
|
BSEP inhibition assay
|
BAO_0010190 |
|
|
secretagogue
|
CHEBI_90414 |
|
|
MRP2 inhibition assay
|
BAO_0010192 |
|
|
insulin secretagogue
|
CHEBI_90415 |
|
|
BCRP inhibition assay
|
BAO_0010191 |
|
|
meter
|
UO_0000008 |
|
|
uptake transporter substrate assay
|
BAO_0010211 |
|
|
transporter substrate assay
|
BAO_0010204 |
|
|
fundamental metabolite
|
CHEBI_78675 |
|
|
temperature unit
|
UO_0000005 |
|
